Hims & Hers Health Gross Profit 2020-2025 | HIMS
Hims & Hers Health annual/quarterly gross profit history and growth rate from 2020 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Hims & Hers Health gross profit for the quarter ending March 31, 2025 was $0.431B, a 88% increase year-over-year.
- Hims & Hers Health gross profit for the twelve months ending March 31, 2025 was $1.375B, a 73.88% increase year-over-year.
- Hims & Hers Health annual gross profit for 2024 was $1.173B, a 64.09% increase from 2023.
- Hims & Hers Health annual gross profit for 2023 was $0.715B, a 74.92% increase from 2022.
- Hims & Hers Health annual gross profit for 2022 was $0.409B, a 99.87% increase from 2021.
| Hims & Hers Health Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $1,173 |
| 2023 | $715 |
| 2022 | $409 |
| 2021 | $204 |
| 2020 | $109 |
| 2019 | $45 |
| 2018 | $0 |
| Hims & Hers Health Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $431 |
| 2024-12-31 | $370 |
| 2024-09-30 | $318 |
| 2024-06-30 | $257 |
| 2024-03-31 | $229 |
| 2023-12-31 | $204 |
| 2023-09-30 | $187 |
| 2023-06-30 | $170 |
| 2023-03-31 | $153 |
| 2022-12-31 | $132 |
| 2022-09-30 | $114 |
| 2022-06-30 | $87 |
| 2022-03-31 | $75 |
| 2021-12-31 | $62 |
| 2021-09-30 | $55 |
| 2021-06-30 | $47 |
| 2021-03-31 | $40 |
| 2020-12-31 | $32 |
| 2020-09-30 | $31 |
| 2020-06-30 | $26 |
| 2020-03-31 | $21 |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $10.359B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.950B | 58.46 |
| Tempus AI (TEM) | United States | $11.831B | 0.00 |
| Doximity (DOCS) | United States | $11.347B | 52.53 |
| IRhythm Technologies (IRTC) | United States | $4.875B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.826B | 59.77 |
| Hinge Health (HNGE) | United States | $3.508B | 0.00 |
| Privia Health (PRVA) | United States | $2.682B | 183.33 |
| Enovis (ENOV) | United States | $1.843B | 10.27 |
| Phreesia (PHR) | United States | $1.663B | 0.00 |
| Schrodinger (SDGR) | United States | $1.503B | 0.00 |
| 10x Genomics (TXG) | United States | $1.441B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.420B | 0.00 |
| Azenta (AZTA) | United States | $1.409B | 65.47 |
| Omnicell (OMCL) | United States | $1.351B | 23.83 |
| Evolent Health (EVH) | United States | $1.262B | 107.50 |
| Claritev (CTEV) | United States | $0.703B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.597B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.500B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.460B | 137.50 |
| Outset Medical (OM) | United States | $0.357B | 0.00 |
| TruBridge (TBRG) | United States | $0.355B | 787.33 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.165B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| American Well (AMWL) | United States | $0.118B | 0.00 |
| Pulmonx (LUNG) | United States | $0.104B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.096B | 3.68 |
| 111 (YI) | China | $0.064B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |